Outcomes after radical prostatectomy among men who are candidates for active surveillance: Results from the SEARCH database

Christopher J. Kane, Ronald Im, Christopher Amling, Joseph C. Presti, William J. Aronson, Martha K. Terris, Stephen J. Freedland

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Objective: We sought to evaluate outcomes after radical prostatectomy among men with low-risk prostate cancer who would be candidates for active surveillance. Methods: Using the Shared Equal Access Regional Cancer Hospital (SEARCH) database of men treated with radical prostatectomy at multiple equal-access medical centers between 1988 and 2007, 398 of 2062 men (19%) met our criteria for potential active surveillance: clinical stage T1c or T2a, prostate-specific antigen (PSA)

Original languageEnglish (US)
Pages (from-to)695-700
Number of pages6
JournalUrology
Volume76
Issue number3
DOIs
StatePublished - Sep 2010
Externally publishedYes

Fingerprint

Cancer Care Facilities
Prostatectomy
Databases
Prostate-Specific Antigen
Prostatic Neoplasms

ASJC Scopus subject areas

  • Urology
  • Medicine(all)

Cite this

Outcomes after radical prostatectomy among men who are candidates for active surveillance : Results from the SEARCH database. / Kane, Christopher J.; Im, Ronald; Amling, Christopher; Presti, Joseph C.; Aronson, William J.; Terris, Martha K.; Freedland, Stephen J.

In: Urology, Vol. 76, No. 3, 09.2010, p. 695-700.

Research output: Contribution to journalArticle

Kane, Christopher J. ; Im, Ronald ; Amling, Christopher ; Presti, Joseph C. ; Aronson, William J. ; Terris, Martha K. ; Freedland, Stephen J. / Outcomes after radical prostatectomy among men who are candidates for active surveillance : Results from the SEARCH database. In: Urology. 2010 ; Vol. 76, No. 3. pp. 695-700.
@article{b4fd41d077854a4888eaf55c9692cef9,
title = "Outcomes after radical prostatectomy among men who are candidates for active surveillance: Results from the SEARCH database",
abstract = "Objective: We sought to evaluate outcomes after radical prostatectomy among men with low-risk prostate cancer who would be candidates for active surveillance. Methods: Using the Shared Equal Access Regional Cancer Hospital (SEARCH) database of men treated with radical prostatectomy at multiple equal-access medical centers between 1988 and 2007, 398 of 2062 men (19{\%}) met our criteria for potential active surveillance: clinical stage T1c or T2a, prostate-specific antigen (PSA)",
author = "Kane, {Christopher J.} and Ronald Im and Christopher Amling and Presti, {Joseph C.} and Aronson, {William J.} and Terris, {Martha K.} and Freedland, {Stephen J.}",
year = "2010",
month = "9",
doi = "10.1016/j.urology.2009.12.073",
language = "English (US)",
volume = "76",
pages = "695--700",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Outcomes after radical prostatectomy among men who are candidates for active surveillance

T2 - Results from the SEARCH database

AU - Kane, Christopher J.

AU - Im, Ronald

AU - Amling, Christopher

AU - Presti, Joseph C.

AU - Aronson, William J.

AU - Terris, Martha K.

AU - Freedland, Stephen J.

PY - 2010/9

Y1 - 2010/9

N2 - Objective: We sought to evaluate outcomes after radical prostatectomy among men with low-risk prostate cancer who would be candidates for active surveillance. Methods: Using the Shared Equal Access Regional Cancer Hospital (SEARCH) database of men treated with radical prostatectomy at multiple equal-access medical centers between 1988 and 2007, 398 of 2062 men (19%) met our criteria for potential active surveillance: clinical stage T1c or T2a, prostate-specific antigen (PSA)

AB - Objective: We sought to evaluate outcomes after radical prostatectomy among men with low-risk prostate cancer who would be candidates for active surveillance. Methods: Using the Shared Equal Access Regional Cancer Hospital (SEARCH) database of men treated with radical prostatectomy at multiple equal-access medical centers between 1988 and 2007, 398 of 2062 men (19%) met our criteria for potential active surveillance: clinical stage T1c or T2a, prostate-specific antigen (PSA)

UR - http://www.scopus.com/inward/record.url?scp=77954892457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954892457&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2009.12.073

DO - 10.1016/j.urology.2009.12.073

M3 - Article

C2 - 20394969

AN - SCOPUS:77954892457

VL - 76

SP - 695

EP - 700

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3

ER -